These projects were made possible from Cure Alzheimer's Fund support.
|APOE Consortium: Assessing the Added Diagnostic Value of Peripheral Apolipoprotein E Protein Levels in Current Blood-Based Biomarker Assays for Central Nervous System Amyloidosis||
|Amyloid Beta Kinetics and Enhancing the Diagnostic and Prognostic Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease||
|Stable Isotope Labeling and Quantitative Mass Spectrometry Imaging of Alzheimer’s Disease Pathology in Human Brain||
2017 and 2019
|APOE Proteoforms in Human CNS and Validation of APOE Pharmacodynamic Translational Markers||
2017 and 2018
|Orbitrap Fusion Tribrid Mass Spectrometer||
These published papers resulted from Cure Alzheimer’s Fund support.
Norelle C. Wildburger, Thomas J. Esparza, Richard D. LeDuc, Ryan T. Fellers, Paul M. Thomas, Nigel J. Cairns, Neil L. Kelleher, Randall J. Bateman, David L. Brody Diversity of Amyloid-beta Proteoforms in the Alzheimer’s Disease Brain, Scientific Reports, 7, 25 Aug 2017, Read More